BRAF and melanoma: Further demonstrating the role of mitochondrial metabolism in MAPKi resistance in melanoma, inhibition of OXPHOS using IACS-010759, a potent and specific inhibitor of electron transport chain Complex 1, induced regression of both intrinsic and acquired MAPKi-resistant BRAF-mutant human melanoma cells in vivo [81].